Onsite Guide - Pri-Med

Transcription

Onsite Guide
PRI-MED SOUTHWEST
Houston, Texas
March 12–14, 2015
March 12
Primary Care Updates
March 13–14
Annual Conference
Curriculum is developed by Pri-Med and its Medical Education Advisory Board, which includes members from the American College of Physicians
and Baylor College of Medicine.
Please Join Us
for a Product Theater Presentation at
Pri-Med Southwest 2015
Friday
March 13, 2015
GEORGE R. BROWN
CONVENTION CENTER
Presentation Theater #3
Room #310
Houston, Texas
This is a promotional event. CE/CME credit
will not be available for this session.
In compliance with PhRMA guidelines,
spouses or other guests are not permitted
to attend company-sponsored programs.
This promotional educational activity is brought
to you by Salix Pharmaceuticals and is not
certified for continuing medical education.
The speakers are presenting on behalf of
Salix Pharmaceuticals and must present
information in compliance with FDA requirements
applicable to Salix Pharmaceuticals.
If you are licensed in any state or other
jurisdiction (eg, VT, Wash. DC, ME, MN) or are
an employee or contractor of any organization
or governmental entity that limits or prohibits
meals from pharmaceutical companies, please
identify yourself so that you (and we) are able
to comply with such requirements. Your name,
the value, and the purpose of any educational
item, meal, or other items of value you receive
may be reported as required by state or federal
law. Once reported, this information may be
publicly accessible.
Thank you for your cooperation.
8:55 am – 9:40 am
STEVEN FLAMM, MD
Chief, Liver Transplantation
Northwestern Memorial Hospital
Professor of Medicine & Surgery
Northwestern University
Feinberg School of Medicine
Chicago, Illinois
Indication
XIFAXAN® (rifaximin) 550 mg tablets are indicated for
reduction in risk of overt hepatic encephalopathy (HE)
recurrence in patients ≥ 18 years of age.
Important Safety Information about XIFAXAN 550 mg
XIFAXAN® (rifaximin) 550 mg tablets are contraindicated
in patients with a hypersensitivity to rifaximin, any of the
rifamycin antimicrobial agents, or any of the components
in XIFAXAN. Hypersensitivity reactions have included
exfoliative dermatitis, angioneurotic edema, and anaphylaxis.
Clostridium difficile-associated diarrhea (CDAD) has
been reported with use of nearly all antibacterial agents,
including XIFAXAN, and may range in severity from mild
diarrhea to fatal colitis. Treatment with antibacterial agents
alters the normal flora of the colon which may lead to
overgrowth of C. difficile. If CDAD is suspected or
confirmed, ongoing antibiotic use not directed against
C. difficile may need to be discontinued.
There is increased systemic exposure in patients with more
severe hepatic dysfunction. The clinical trials were limited
to patients with MELD scores < 25. Therefore, caution
should be exercised when administering XIFAXAN to
patients with severe hepatic impairment (Child-Pugh C).
Concomitant administration of drugs that are
P-glycoprotein (P-gp) inhibitors with XIFAXAN can
substantially increase the systemic exposure to XIFAXAN.
Caution should be exercised when concomitant use of
XIFAXAN and a P-gp inhibitor such as cyclosporine is
needed. In patients with hepatic impairment, a potential
additive effect of reduced metabolism and concomitant
P-gp inhibitors may further increase the systemic exposure
to XIFAXAN.
Based on animal data, XIFAXAN may cause fetal harm.
Discontinue in nursing mothers after taking into account
the importance of the drug to the mother.
The most common adverse reactions occurring in ≥ 10%
of patients and at a higher incidence than placebo in
the clinical study were peripheral edema (15%),
nausea (14%), dizziness (13%), fatigue (12%), and
ascites (11%).
Xifaxan 550 mg is licensed by Alfa Wassermann S.p.A.
to Salix Pharmaceuticals, Inc.
Please see complete Prescribing Information for
XIFAXAN at Salix booth #500.
Presented by
© 2015 Salix Pharmaceuticals, Inc.
January 2015
XIFH-US-0037
Table of Contents
General Conference Information . . . . . . . . . . . . . . . 4-5
Primary Care Updates Sessions . . . . . . . . . . . . . . . . . 6
Annual Conference Session Schedule . . . . . . . . . . . . 8-11
Featured Sessions . . . . . . . . . . . . . . . . . . . . . . . . . 12
Continuing Medical Education Information . . . . . . . . 14-15
Primary Care Updates Session Information . . . . . . . . 16-17
Annual Conference Session Information . . . . . . . . . . 17-20
Speaking Faculty for Primary Care Updates
and Annual Conference . . . . . . . . . . . . . . . . . . . .22-23
Financial Disclosures . . . . . . . . . . . . . . . . . . . . . 24-25
Exhibitors . . . . . . . . . . . . . . . . . . . . . . . . . . . 26-28
Maps of the Convention Center . . . . . . . . . . . . . . .29-31
Hours of Operation
Registration: Hall B3, Level 3
Thursday, March 12
6:45am–3:30pm
Friday, March 13
6:45am–4:30pm
Saturday, March 14
6:45am–2pm
SYLLABUS: WWW.PRI-MED.COM/SOUTHWEST/SYLLABUS
Exhibit Hall
Friday, March 13
Saturday, March 14
8:30am–4pm
8:30am–4pm
PRI-MED SOUTHWEST
3
GENERAL CONFERENCE INFORMATION
Badge Correction/Lost Badges
Annual Conference Syllabus
The session slides presented at Pri-Med Southwest are
available online at www.pri-med.com/southwest/syllabus
for eight weeks following the conference.
Attendee Badge
As a Pri-Med attendee, you will receive a badge
programmed with your name, address, and profession.
Please scan your QR Code once per day at the Xpress
Registration Counters (Hall B3, Level 3) and at the
entrances to some stand-alone CME activities to be
eligible to obtain CME credit or nursing contact hours.
Scanning your QR code at an exhibit booth or a nonCME activity gives the sponsor permission to use your
contact information for future correspondence.
If you have lost your badge or the badge has been prepared
incorrectly, please go to the Pri-Med Registration Services located
on Level 3 in Hall B3, where a new badge will be prepared.
Lost and Found
Any lost or found items can be delivered to or picked up
at the Information Booth located in Hall B3, Level 3.
Management Office
The Management Office is located in Room 340A on
Level 3. You are invited to visit us in this office anytime
you feel that we can be of assistance to you.
Questions?
We’re here to help! Please visit the Information Booth
located on Level 3 in Hall B3 or the Pri-Med Booth, #301,
or find any Pri-Med staff member for assistance.
Spouse/Children Attendance
NEW PROCESS for Evaluation and
Claiming Education Credit
Pri-Med’s credit award procedure has changed.
Please follow these instructions for evaluating
and claiming continuing education credit for
sessions you attend at this Pri-Med meeting:
1. Scan your badge once each day at the Xpress
Registration Counters (Hall B3, Level 3) to
activate your identification for credit award.
2. Go to www.pri-med.com/southwest/eval to
access the online credit system, using any computer
or Internet-interactive device, and complete the
evaluation and credit request process. You have 7 days
to complete this process—until Saturday, March 21,
2015. Pri-Med staff can assist you with the process if
you have questions, and computers are available in the
registration area:
A. Enter your badge number and email
address for identification.
B. To evaluate each session, select the day, then
the session title, and complete the evaluation.
When you have evaluated the sessions you
attended, then evaluate the overall activity.
C. Confirm total credit award and attest to correct
total. Designate the type of credit you seek.
3. Receive your credit. View and print your certificate right
from the evaluation website. Your certificate will also
be posted to your Pri-Med.com account the next day.
4
PRI-MED SOUTHWEST
Spouses and/or significant others of registered
professional attendees may attend the Pri-Med Exhibit
Hall when accompanied by a professional attendee. These
individuals should go to the Xpress registration counter
and register for a guest badge for $35. We regret that
because of space limitations we cannot accommodate
guest registrants in the conference sessions.
So that we can provide all Pri-Med attendees with optimal
learning environments, children under the age of 16 years
are not permitted in the Exhibit Hall or the session rooms.
Complimentary Wi-Fi
Complimentary Wi-Fi is sponsored
by Janssen Pharmaceuticals, Inc.
Network Name: Janssen Diabetes Solutions
Password: Invokanabooth209
Notice: Physician Payment Sunshine Act
In adherence to federal regulations, physicians are advised
that your information, including your name and the value and
purpose of any meal, beverage, educational item, or other
items of value you receive from a pharmaceutical company,
medical device manufacturer, or group purchasing organization
may be reported by these organizations for public disclosure.
If you have questions or are unsure whether an item you wish
to accept is reportable, please ask a company representative
at the appropriate booth for more information.
For the full Physician Payment Sunshine Act policy, visit
www.CMS.gov under Regulations and Guidance, National
Physician Payment Transparency Program (Open Payments).
GENERAL CONFERENCE INFORMATION
2016 PRI-MED SOUTHWEST REGISTRATION
Register for next year’s Annual Conference for just $40.
The conference is June 23-25, 2016, in Houston, TX.
Follow the orange footsteps in the Exhibit Hall to the Pri-Med Booth #301 or visit the 2016 Next Registration Counter
on Level 3 in Hall B3. You will also have the opportunity to purchase a Fitbit activity tracker at a preferred rate during
registration and to participate in our Steps to Success community.
Fitbit activity trackers are limited in availability. Limit 1 Fitbit activity tracker per
2016 registrant. You must register for the 2016 Annual Conference to qualify.
TICKETING
Preconference Online Ticketing Process: You spoke and we listened. Based on past attendee
feedback, we made some improvements to our ticketing policy—you were able to choose your Ticketed Events
online before the conference even started and forgo standing in the Ticket Booth line!
• Ticket Distribution: the Ticketed Events for which you preregistered will print out with your conference badge,
so you’ll have only one stop for checking in.
• Standby Lines: if you were unable to register for Ticketed Events that you want to attend, non-ticket-holder lines
are available for the Ticketed Events, and we will accommodate as many clinicians as possible.
Pri-Med is committed to helping improve your health and wellness, so we’re covering part of the cost of your
activity tracker. Indicate interest in purchasing yours during onsite registration for the 2016 Annual Conference
and participate in the Steps to Success community. Prizes will be awarded throughout the walking challenge.
You are eligible for
one of the following
products at a preferred
rate if you preregister
onsite for Pri-Med
Southwest 2016:
Fitbit Zip: Your Price $30 | Retail Price: $59.95
Fitbit One: Your Price $59.50 | Retail Price: $99.95
Fitbit Flex: Your Price $59.50 | Retail Price: $99.95
Fitbit Charge: Your Price $82.75 | Retail Price: $129.95
Fitbit Charge HR: Your Price $102 | Retail Price: $149.95
Fitbit Surge: Your Price $179 | Retail Price: $249.95
‘16
SEE YOU NEX T YEAR!
Register for the 2016 Annual Conference (June 23-25, 2016)
at Pri-Med Booth #301 or at the 2016 Next Year Registration
Counter. Registration is available at the lowest cost of $40.
PRI-MED SOUTHWEST
5
PRIMARY CARE UPDATES SESSIONS
THURSDAY, MARCH 12, 2015
Track 1
7:45–9am
Track 2
Session 1 – Update on Immunizations
in High Risk Adults
Session 1 – New Drugs for PCP:
What You Need to Know
M. Susan Burke, MD, FACP
Barbara P. Yawn, MD, MSc, FAAPP
Gerald W. Smetana, MD
George Bush Ballroom
Hall B3
Morning Break
9–9:15am
9:15–10:30am
Session 2 – Meeting the Challenge
of Managing Lipids Beyond LDL-C
Sergio Fazio, MD, PhD, FAAP, FASCI
Peter H. Jones, MD, FNLA, FACP
Hall B3
Session 2 – A Focus on Bipolar
Depression: Overcoming Diagnostic
Barriers and Optimizing Long-Term
Patient Outcomes
Joseph R. Calabrese, MD
Roger S. McIntyre, MD, FRCPC
10:30–11:45am
Session 3 – Evolving Insulin Therapy:
Optimizing Care Through Proper
Selection & Use
Jessica Castle, MD
Intekhab Ahmed, MD, FACE, FACP
Session 3 – Getting Your Patients to
Weigh In: Discussing Approaches to
Treating Obesity in the Primary Care
Setting
Donna H. Ryan, MD
Holly Wyatt, MD
Hall B3
Lunch Break
11:45am–12:30pm
12:30–1:45pm
Session 4 – Optimizing the Diagnosis,
Treatment, and Management of
Irritable Bowel Syndrome
Session 4 – Migraine Headaches: Tools
for Successful Management
Spencer Dorn, MD, MPH, MHA
Brooks D. Cash, MD
Hall B3
Afternoon Break
1:45–2pm
2–3:15pm
Session 5 – Clinical Updates in
Idiopathic Pulmonary Fibrosis
Hall B3
Session 5 – Combining GLP-1 Receptor
Agonists with Basal Insulin: Realizing
the Potential in Type 2 Diabetes
Dace Trence, MD, FACE
There are no session restrictions for Primary Care Updates—you may attend any sessions you want on
Thursday, March 12 and any of the core CME curriculum sessions for the remainder of the conference.
Schedule and sessions subject to change.
6
PRI-MED SOUTHWEST
FEATURED ACTIVITIES
Case Challenge: Management of
Shift Work Disorder - Christina, 46
The Role of Opioids in Multimodal Treatment
Approaches to Acute Pain
•
•
•
•
Multimedia/Patient Case Study
Up to 0.50 credits*
Rare Cases in Angioedema: Lifting the
Veil on a Potentially Fatal Disease
•
•
Multimedia/Webcast
Up to 1.25 credits*
Text-based
Up to 0.50 credits*
62-year old male with dyspnea on exertion
•
•
Text-based
Up to 0.50 credits*
Current Perspectives and Emerging
Approaches in Lipid Management
Beyond Digestion: The Role of Fiber in
Cardiometabolic Health
•
•
•
•
Multimedia/Webcast
Up to 1.50 credits*
Text-based
Up to 1.00 credit*
*pmiCME is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. pmiCME designates these
enduring activities for the above listed AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in each activity.
pmiCME is approved as a provider of nurse practitioner continuing education programs by the American Association of Nurse Practitioners. AANP Provider number 040308. The
above activities were planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standards. These activities have been approved for the above listed
contact hours. Please see activity CME information for full information on credit designation and instructions.
**Pri-Med Qlikview database, July 2014
Provided by pmiCME
ANNUAL CONFERENCE AGENDA
FRIDAY, MARCH 13, 2015
7:45–8:45am
KEYNOTE: The Power of Lifestyle Changes, Social Networks, & Trust
Dean Ornish, MD
Hall B3
NETWORKING BREAK AND ADDITIONAL OPPORTUNITIES
8:45–9:45am
8:55–9:40am
Pneumococcal
Pneumonia and
Invasive Disease
in Adults: Help
Protect Patients
Aged 65+ in Your
Practice
HARVONI:
Changing What
is Possible with a
Simple Treatment
Regimen
Hepatic
Encephalopathy:
Understanding the
CNS Dysfunction as a
Result of Cirrhosis
Advancing the
Knowledge of
Triglycerides
Brought to you by
Gilead Sciences, Inc.
Brought to you by
Pfizer, Inc.
Exhibit Hall, Theater 2
Brought to you by
Salix Pharmaceuticals, Ltd. Room 320 C
Brought to you
by AstraZeneca
Pharmaceuticals LP
Room 310
9:45–10:30am
Hypertension Management:
A Moving Target
Testosterone Therapy:
Examining the Evidence
Karol Watson, MD, PhD, FACC
Culley Carson, MD
Update on the Pathogenesis of the
Acute Coronary Syndromes
The Prostate: BPH and Beyond
Peter Libby, MD, FACC
Cardiovascular Panel Discussion
Men’s Health Panel Discussion
Culley Carson, MD
Mohit Khera, MBA, MD, MPH
Hall B3
10:30–11:15am
Mohit Khera, MBA, MD, MPH
Hall B3
11:15–11:30am
Hall B3
LUNCH BREAK AND ADDITIONAL OPPORTUNITIES
11:30am–1pm
11:40am–
12:55pm
Educational Symposium for Cardiologists: Latest Advances in Secondary Prevention
of Cardiovascular Events
Support for this educational symposium is provided by Merck & Co., Inc.
Location: Ballroom C
Ticket required for entry. This session is designed for cardiologists currently engaged in patient care and
physicians who practice primarily in the management of adult patients with cardiovascular diseases.
8
PRI-MED SOUTHWEST
12–12:45pm
An Introduction to Chronic
Hepatitis B – Partnering to
Act on Hepatitis B Virus in
Your Community
Brought to you by Gilead
Sciences, Inc.
The Effect of a OnceWeekly Therapy on A1C
and Weight Over 3 Years
Brought to you by
AstraZeneca Diabetes
Understanding Dupuytren’s
Contracture: Disease
Awareness for the General
Practitioner. Indication:
XIAFLEX® is indicated for the
treatment of adult patients
with Dupuytren’s contracture
with a palpable cord
Brought to you by Auxilium
Pharmaceuticals, Inc.
Room 320 C
1–2:15pm
Optimizing Insulin Therapy for
Patients with Type 2 Diabetes: Existing
Challenges and New Opportunities for
Improved Care
Evaluating the Evidence for Hormone
Therapy in Menopausal Women
Ki Park, MD
Bruce W. Bode, MD, FACE
Lawrence Blonde, MD, FACP, FACE
Hall B3
2:15–3pm
Diagnosis and Management of Urinary
Incontinence
Eating Disorders for the
Primary Care Clinician
Mohit Khera, MBA , MD, MPH
Sindhu Idicula, MD
Sharonda Alston-Taylor, MD
Hall B3
3–4pm
3:10–3:55 pm
A Paradigm Shift In The
Treatment of Thrombosis
Curing Chronic HCV
Brought to you by Janssen
Brought to you by AbbVie
Brought to you by Arbor
4–5pm
Room 310
Preventive Medicine that Works:
Adult Immunization
Primary Care Approach to
Mood Disorders
Robert Hopkins Jr., MD, FACP, FAAP
Alan Swann, MD
Controversies in Osteoporosis
Prevention and Management
Review and Update of Drug Therapy
for Major Depressive Disorder
Carolyn Crandall, MD
Sanjay Mathew, MD
Hall B3
5–6pm
A Change of Heart - Achieving
Best Outcomes When Caring for
African American HF Patients
Hall B3
Pri-Med Southwest Annual Conference
Partial support by industry. See page 14.
Non-CME session
supported by industry
Education Symposium
supported by industry
PRI-MED SOUTHWEST
9
ANNUAL CONFERENCE AGENDA
SATURDAY, MARCH 14, 2015
7:45–8:45am
KEYNOTE: Dharma, Happiness and Purpose
Sanjiv Chopra, MD, MACP
Hall B3
8:45–9:45am
8:55–9:40am
Advanced Insight
into Residual
Cardiovascular
Risk: A
Comprehensive
Approach for
helping you
assess risk, guide
treatment, and
monitor response
The Prevalence
of Dyslipidemia
in Diabetes:
Cholesterol
Management and
the Role of PCSK9
in Cholesterol
Homeostasis
Brought to you by
Quest Diagnostics
Expert Views®:
Demystifying
Probiotics
Brought to you
by P&G Personal
Health Care
Room 310
Supporting Nurse
Practitioners and
Physician Assistants
in Diabetes Care:
Targeting the
Kidney in Type 2
Diabetes
Brought to you
by Janssen
Brought to you by
Amgen, Inc.
Room 320 C
9:45–10:45am
Spotlight on Hepatitis C Infection
Sammy Saab, MD, MPH, AGAF
Hall B3
New Approaches to Treating C Difficile
Infection
Kalpana Gupta, MD, MPH
10:45–11:45am
A Tale of Two Brains
Salvatore Mangione, MD
Hall B3
Clinical Practice Guidelines for the
Management of Thyroid Disorders
Gregory Brent, MD
LUNCH BREAK AND ADDITIONAL OPPORTUNITIES
11:45am–1pm
12–12:45pm
An Individualized
Approach to the
Treatment of Adults with
Type 2 Diabetes
Understanding the
Data on EPI (Exocrine
Pancreatic Insufficiency)
Medical Mystery: A Case
of Unexplained Recurrent
Abdominal Pain
Brought to you by AbbVie
Brought to you by Shire
Brought to you by Janssen
Room 310
10
PRI-MED SOUTHWEST
1–1:30pm
Virtual Clinical Coffee Break:
Advances and Options in Female
Contraception
Virtual Clinical Coffee Break: Practical Tips
for Management of ADHD
Pelin Batur, MD
Ebola Update
Walking the Line: A Primer on Gait Analysis
Cascade Effects in Primary Care
Medicine
Therapeutic Considerations in the
Management of Childhood Obesity
Courtenay Bruce, JD, MA
Teresia O’Connor, MD, MPH
Thomas Cummins, MD
Hall B3
1:30–2pm
Hall B3
2–2:45pm
Hall B3
2:45–3:45pm
2:55–3:40pm
Addressing Chronic
Weight Management
With Targeted
Pharmacotherapy
Brought to you by Eisai Inc.
Breaking Through the
Frustration of Major
Depressive Disorder [MDD]:
Understanding the Disease
and Improving Treatment
Outcomes
Brought to you by Otsuka
America Pharmaceutical, Inc.
and Lundbeck
Discussion of an
Anticoagulant for Treatment
of Nonvalvular Atrial
Fibrillation and Venous
Thromboembolism
Brought to you by
Daiichi Sankyo, Inc.
Room 310
3:45–4:45pm
Recommendations for Assessing and
Treating Irritable Bowel Syndrome
and Its Complications
Screening Guidelines for Men’s Health
Radha Rao, MD
Hashem El-Serag, MD, MPH
Hall B3
4:45–5:30pm
Diagnosis and Treatment
of Gallstone Diseases
Advances in Managing COPD Patients
Kalpesh Patel, MD
Nicola Hanania, MD, FCCP, FRCP, FACP
Hall B3
Partial support by industry. See page 14.
Non-CME session supported by industry
PRI-MED SOUTHWEST
11
FEATURED SESSIONS
Keynote Addresses
FRIDAY, MARCH 13
SATURDAY, MARCH 14
7:45–8:45am
7:45–8:45am
The Power of Lifestyle Changes,
Social Networks & Trust
Dean Ornish, MD
Dharma, Happiness and Purpose
Dr. Sanjiv Chopra is a professor of medicine at Harvard Medical
Dr. Dean Ornish is the founder and president of the
School. He is also the James Tullis Firm Chief in the Department of
nonprofit Preventive Medicine Research Institute and
Medicine and a senior consultant in hepatology at the Beth Israel
Clinical Professor of Medicine at the University
Deaconess Medical Center, Boston.
of California, San Francisco.
He served as Faculty Dean for Continuing Education at Harvard
Dr. Ornish received his medical training in internal
Medical School for 12 years. Dr. Chopra has more than 150
medicine from the Baylor College of Medicine, Harvard
publications and seven books to his credit. His brother Deepak and he
Medical School, and the Massachusetts General Hospital.
have written a double memoir: “Brotherhood: Dharma, Destiny and
He has directed clinical research demonstrating, for the
the American Dream,” published in 2013. It is a national best seller.
first time, that comprehensive lifestyle changes may
begin to reverse even severe coronary heart disease,
without drugs or surgery. He is the author of six bestselling books and was chosen by LIFE magazine as “one
of the 50 most influential members of his generation” and
by Forbes magazine as “one of the seven most powerful
teachers in the world.”
12
PRI-MED SOUTHWEST
Pri-Med’s credit award procedure
has changed. Please follow these
instructions for evaluating and
requesting continuing education
credit for sessions you attend at
this Pri-Med meeting:
1. Scan your badge once each day at the Xpress
Registration Counters (Hall B3, Level 3) to activate
your identification for credit award.
2. Go to www.pri-med.com/southwest/eval to access
the online credit system, using any computer or
Internet-interactive device, to complete the
evaluation and credit request process. You have
7 days to complete the process—until Saturday,
March 21, 2015. Pri-Med staff can assist you with the
process if you have questions and computers are
available in the registration area:
a.
Enter your badge number and email address
for identification.
b.
To evaluate each session, select the day, then the
session title, and complete the evaluation. When
you have evaluated the sessions you attended,
then evaluate the overall activity.
c.
Confirm total credit award and attest to correct
total. Designate the type of credit you seek.
3. Receive your credit. View and print your certificate
right from the evaluation website. Your certificate
will also be posted to your Pri-Med.com account the
next day.
CONTINUING MEDICAL EDUCATION INFORMATION
PRIMARY CARE UPDATES
March 12, 2015
Primary Care Updates is provided by pmiCME, the accredited
division of Pri-Med
Target Audience
This activity is intended for clinicians in primary care, family
medicine, pediatrics, and internal medicine.
Learning Objectives*
Following participation in this activity you should be able to
• Evaluate new guidelines and evidence-based practices
and therapies
• Enhance your ability to diagnose, treat, and manage
health problems you see in your practice
• Implement current best practices to encourage the
adoption of health-promoting behaviors, avoid unnecessary
subspecialty consults, and improve your patients’ quality of life
• Commit to specific personal practice improvements *See session information for topic-specific learning objectives
Commercial Support
Primary Care Updates is supported by educational grants from
Amarin Pharma Inc.; Boehringer Ingelheim Pharmaceuticals,
Inc.; Forest Laboratories Inc.; Merck & Co., Inc.; Novo Nordisk Inc.;
sanofi-aventis U.S.; and Sunovion Pharmaceuticals Inc.
Faculty Credentials and Financial Disclosures
Please see pages 22-25 for financial disclosure information
for faculty and other content contributors.
Accreditation and Credit Designation
PRI-MED SOUTHWEST
ANNUAL CONFERENCE
March 13–14, 2015
Pri-Med Southwest Annual Conference is provided by pmiCME,
the accredited division of Pri-Med.
The curriculum is developed by Pri-Med and its Medical
Education Advisory Board, which includes members from the
American College of Physicians, Baylor College of Medicine,
David Geffen School of Medicine at UCLA, Harvard University
School of Medicine, Northwestern University Feinberg School
of Medicine, University of Massachusetts School of Medicine,
and University of Miami Miller School of Medicine.
Target Audience
This activity is intended for clinicians in primary care, family
medicine, pediatrics, and internal medicine.
Learning Objectives*
Following participation in this activity you should be able to
• Evaluate new guidelines and evidence-based practices
and therapies
• Enhance your ability to diagnose, treat, and manage
health problems you see in your practice
• Implement current best practices to encourage the
adoption of health-promoting behaviors, avoid
unnecessary subspecialty consults, and improve your
patients’ quality of life
• Commit to specific personal practice improvements
*See session information for topic-specific learning objectives
• ACCME Accreditation Statement
pmiCME is accredited by the Accreditation Council for
Continuing Medical Education to provide continuing medical
education for physicians.
Commercial Support
• AMA PRA Designation Statement
pmiCME designates this live activity for a maximum of
6.25 AMA PRA Category 1 Credits™. Physicians should
claim only the credit commensurate with the extent of their
participation in the activity.
Faculty and Financial Disclosures
• American Academy of Family Physicians
This live activity, Primary Care Updates from 3/12/15 to
3/12/15, has been reviewed and is acceptable for up to
6.25 prescribed credit(s) by the American Academy of Family
Physicians (AAFP).
• American Association of Nurse Practitioners
pmiCME is approved as a provider of nurse practitioner
continuing education by the American Association of Nurse
Practitioners. AANP provider 040308. This program has been
approved for 6.25 contact hours of continuing education
(which include 3.25 hours of pharmacology).
14
PRI-MED SOUTHWEST
The Annual Conference is partially supported by a grant from
sanofi-aventis U.S.
See pages 22-25 for a full list of program faculty and financial
disclosure information.
Accreditation and Credit Designation
• ACCME Accreditation Statement
pmiCME is accredited by the Accreditation Council for
Continuing Medical Education to provide continuing
medical education for physicians.
• AMA PRA Designation Statement
pmiCME designates this live activity for a maximum of
13.25 AMA PRA Category 1 Credits™. Physicians should claim
only the credit commensurate with the extent of their
participation in the activity.
CONTINUING MEDICAL EDUCATION INFORMATION
• American Academy of Family Physicians
This live activity, Pri-Med Southwest Annual Conference
from 3/13/15 to 3/14/15, has been reviewed and is
acceptable for up to 13.25 prescribed credit(s) by the
American Academy of Family Physicians (AAFP).
• American Association of Nurse Practitioners
pmiCME is approved as a provider of nurse practitioner
continuing education by the American Association of
Nurse Practitioners. AANP provider 040308. This program
has been approved for 13.25 contact hours of continuing
education (which include 6.75 hours of pharmacology).
SESSION
CUMULATIVE
AMA PRA Category 1
Credits™ or
AANP Contact Hours
(AANP Pharmacology)
AMA PRA Category 1
Credits™ or
AANP Contact Hours
(AANP Pharmacology)
Morning Sessions
3 (1.5)
3 (1.5)
Afternoon Sessions
3.75 (2)
6.75 (3.5)
3 (1.5)
9.75 (5)
3.5 (1.75)
13.25 (6.75)
Day 1
Day 2
Morning Sessions
Afternoon Sessions
About pmiCME
Pri-Med programs are owned and operated by DBC
Pri-Med, LLC, a division of Diversified Communications,
located in Boston, Massachusetts. The accredited provider for
this program is pmiCME, the accredited division of Pri-Med.
Accredited with Commendation by the ACCME and
approved as a provider of continuing education by the
AANP, pmiCME ensures that Pri-Med continuing education
programs are high-quality, credited learning experiences
for participants, faculty speakers, and supporters alike.
pmiCME provides conferences, an online learning platform,
and innovative forms of distance education in order to
contribute to the continuing professional development
of health care providers and to influence clinical practice
behaviors for the purpose of improving health outcomes.
Academic Partnerships
Disclosure and Conflict of Interest
Resolution Policy
pmiCME requires all individuals in a position to influence
educational content for pmiCME-certified CME activities
to disclose relevant personal financial relationship(s) with
commercial interests prior to contributing to the activity.
pmiCME assesses disclosed relationships and follows a defined
process to resolve real or implied conflicts to ensure, to the best
of our ability, that all educational content is free of commercial
bias. Financial disclosures are listed in this guidebook and will
also be announced prior to the start of each presentation and
posted on www.pri-med.com.
Discussion of Off-Label Uses
and Investigational Products
During the course of their presentations, the faculty may
mention uses of products that have not been approved in
the United States for the indication(s) being discussed. All
presenters are instructed to notify participants when they
are discussing unapproved uses or investigational agents. In
addition, specific slides will include notation of the off-label
use or investigational agent being discussed. Views presented
during this program related to unapproved uses of products
are solely those of the presenter(s) and are not endorsed by
pmiCME or DBC Pri-Med, LLC.
Disclaimer
No part of this program syllabus may be reproduced or
otherwise incorporated into any information retrieval system
without the written permission of DBC Pri-Med, LLC. The
opinions, recommendations, and perspectives expressed in
the syllabus and accompanying presentations are those of
the faculty only and do not necessarily reflect the opinions,
recommendations, or perspectives of their affiliated institutions,
pmiCME, Diversified Communications, or commercial
supporters. Clinical judgment must guide each clinician in
weighing the benefit of any intervention or treatment against
the risk of the intervention or treatment. Dosage, indications,
and methods of use for products referred to in this program are
not necessarily the same as indicated in the package insert for
the product and may reflect the clinical experience or expertise
of the faculty speaker. No procedures or treatments should
be utilized without evaluation of the patients’ conditions and/
or possible contraindications or risks and without a review of
any applicable product information and comparison with the
recommendations of other authorities.
pmiCME and the American College of Physicians (ACP) gratefully
acknowledge the Baylor College of Medicine and Tufts Health
Care Institute as academic partners providing independent
expert reviews of Annual Conference educational content.
PRI-MED SOUTHWEST
15
SESSION INFORMATION
Session 4 – Optimizing the Diagnosis, Treatment,
and Management of Irritable Bowel Syndrome
Brooks D. Cash, MD
Education Partner: Miller Medical Communications, LLC
Primary Care Updates
Thursday, March 12, 2015
• Diagnose IBS and differentiate from other bowel disorders using
established clinical guidelines
HALL B3
Session 1 – Update on Immunizations in
High Risk Adults
• Summarize the efficacy and safety of pharmacologic and
nonpharmacologic treatment options for IBS
• Implement patient-specific methods for managing IBS symptoms
and improving function and quality of life
Session 5 – Clinical Updates in Idiopathic
Pulmonary Fibrosis
Education Partner: Miller Medical Communications, LLC
• Identify profiles of specific patients at increased risk for
vaccine-preventable diseases
Education Partner: MedEd Consulting
• Describe the epidemiology and pathophysiology of Idiopathic
Pulmonary Fibrosis (IPF) and the importance of early diagnosis
• Implement vaccine recommendations in high-risk patients
• Recognize that health care provider recommendations are
key to patient acceptance of vaccinations
• Review the diagnosis and management of IPF as recommended in
the 2011 ATS/ERS guidelines
• Evaluate the emerging data in IPF treatment options and the impact
this information has on management approaches for existing and
newly diagnosed patients with IPF
Session 2 – Meeting the Challenge of Managing
Lipids Beyond LDL-C
Education Partner: Medtelligence, LLC
GEORGE BUSH BALLROOM
Session 1 – New Drugs for PCP: What You Need to Know
• Discuss the role of elevated triglyceride levels and cardiovascular
risk factors in the assessment and diagnosis of dyslipidemia
• Apply best practices, including assessing fasting and nonfasting
states, to accurately evaluate triglyceride levels
• Learn which recently approved drugs will have the largest impact
on primary care practice
• Use evidence-based practices and guidelines in managing
hypertriglyceridemia to assess appropriate integration of new
and emerging therapeutic approaches to manage TG-based
dyslipidemia, mixed dyslipidemia, and associated cardiovascular risk
• Understand the efficacy, side effects, and cost of important novel
drugs in primary care practice
Session 3 – Evolving Insulin Therapy:
Optimizing Care Through Proper Selection & Use
Session 2 – A Focus on Bipolar Depression:
Overcoming Diagnostic Barriers and Optimizing
Long-Term Patient Outcomes
Jessica Castle, MD
Education Partner: Horizon CME
• Implement strategies for the timely initiation of insulin therapy to
best achieve glycemic control in patients with type 2 diabetes
• Design insulin regimens that are appropriate and tailored to a
patient’s specific needs
• Recognize the barriers to insulin-mediated glucose control and
apply strategies to overcome them
• Outline the pharmacokinetic/pharmacodynamics profiles and
evidence for emerging basal insulins for the treatment of type 2
diabetes
• Learn the role of recently approved medications and their place
among existing therapies
Education Partner: Integritas Communications Group
• Discuss clinically relevant pathophysiology of bipolar disorder,
including epidemiologic and mechanistic relationships with
cardiometabolic disturbances
• Identify patients with bipolar depression based on comprehensive
patient histories, risk factors, key presenting symptoms, and the
latest diagnostic criteria
• Tailor therapeutic regimens for bipolar depression to reflect
efficacy, safety, and tolerability of approved agents and common
patient comorbidities
• Engage patients with bipolar depression to motivate active
participation in ongoing care and improve treatment adherence
16
PRI-MED SOUTHWEST
SESSION INFORMATION
Session 3 – Getting Your Patients to Weigh In:
Discussing Approaches to Treating Obesity in
the Primary Care Setting
Friday, March 13, 2015
Donna H. Ryan, MD
Holly Wyatt, MD
Education Partner: Institute for Medical and Nursing Education
HALL B3
• Summarize current recommendations for screening, assessment,
and treatment goals in the management of adult obesity
• Develop individualized therapeutic regimens for adults with
obesity, incorporating lifestyle management and adjunct therapies
as appropriate, based on current treatment recommendations and
recent evidence
• Utilize clinically validated approaches and tools to engage and
support patients in the management of adult obesity as a chronic
disease
Session 4 – Migraine Headaches:
Tools for Successful Management
• Improve the identification of migraines in the patient with recurring
headache and disability
• Apply the latest evidence-based recommendations for preventive
and abortive migraine treatment
• Recommend complementary and alternative therapies when
indicated
The Power of Lifestyle Changes, Social Networks & Trust
Dean Ornish, MD
• Understand successful strategies for motivating people to make
and maintain comprehensive lifestyle changes
• Describe the evidence from randomized controlled trials showing
that chronic diseases such as coronary heart disease and prostate
cancer may be stopped or even reversed by making comprehensive
lifestyle changes
• Describe the evidence showing that comprehensive lifestyle
changes may affect gene expression
Hypertension Management: A Moving Target
• Review the JNC8 guidelines for hypertension in adults, with special
attention to new blood pressure goals
• Consider patient factors such as age, comorbidities, and race when
prescribing antihypertensive therapy
Update on the Pathogenesis of the Acute
Coronary Syndromes
Session 5 – Combining GLP-1 Receptor Agonists
with Basal Insulin: Realizing the Potential in
Type 2 Diabetes
Education Partner: Horizon CME
• Implement ADA recommendations for A1C, fasting plasma glucose,
and postprandial glucose targets in the management of patients
with type 2 diabetes
• Assess the clinical profiles of GLP-1 receptor agonists and the
advantages and disadvantages of prandial insulin
• Describe the clinical rationale and expected benefits of using
antidiabetic therapies with complementary mechanisms of action
in the treatment of patients with type 2 diabetes
• Utilize appropriate strategies to select and intensify antidiabetic
therapy to achieve PPG control in patients with type 2 diabetes on
basal insulin
• To understand current data regarding the cellular and molecular
pathogenesis of acute coronary syndromes
• To become acquainted with the scientific basis of therapeutic goal
of “plaque stabilization”
• To understand the shifts in the clinical aspects of acute coronary
syndromes in the statin era
• To discuss current and emerging therapies to prevent acute
coronary syndromes
Cardiovascular Panel Discussion
• Learn from faculty examples from their own practices on
interpreting and applying the new hypertension and cholesterol
guidelines
PRI-MED SOUTHWEST
17
SESSION INFORMATION
Optimizing Insulin Therapy for Patients with Type 2
Diabetes: Existing Challenges and New Opportunities
for Improved Care
Testosterone Therapy: Examining the Evidence
• Review the role of testosterone in men’s health
Culley Carson, MD
• Discuss the diagnosis of hypogonadism in men
• Better identify and understand the pathophysiologic defects
contributing to postprandial hyperglycemia and its impact on
managing the glycemic burden in patients with type 2 diabetes
mellitus
• Highlight published treatment guidelines for testosterone
replacement therapy (TRT)
• Discuss recent data on the cardiovascular risk factors for TRT
• Discuss the effects of TRT in general and on the prostate in the
aging male
• Incorporate assessment of postprandial glucose as part of
diagnostic and treatment plan so as to target therapy to better
manage hyperglycemia and prevent potential complications in
patients with type 2 diabetes mellitus
The Prostate: BPH and Beyond
• Overcome both clinician and patient resistance to appropriate
initiation and intensification of insulin therapy to best manage
postprandial hyperglycemia, while lowering risk for adverse events
Mohit Khera, MD, MBA, MPH
• Better distinguish conventional, new, and emerging prandial insulin
therapies for appropriate treatment selection in patients with T2DM
so as to properly integrate in to care and improve outcomes
• Understand how to diagnose and treat men with ED
• Understand how to diagnose and treat men with BPH
• Be familiar with the AUA 2014 updated BPH guidelines
• Understand the relationship between ED and cardiovascular disease
Men’s Health Panel Discussion
Diagnosis and Management of Urinary Incontinence
Culley Carson, MD
• Understand how to diagnose and treat stress incontinence
• Understand from expert faculty examples from their own practices
on BPH/LUTS, erectile dysfunction and testosterone replacement
• Understand how to diagnose and treat urge incontinence
Preventive Medicine That Works: Adult Immunization
Robert Hopkins Jr., MD, FACP, FAAP
• Understand the current gap between national immunization goals
and current immunization rates
Evaluating the Evidence for Hormone Therapy
in Menopausal Women
Ki Park, MD
• Apply up-to-date information about the natural history of
menopause to improve the care of individual women
• Use the current ACIP guidelines to vaccinate your adult patients
• Implement strategies to improve immunization rates in your office
• Counsel women about the risks and benefits of systemic
hormone therapy for menopausal symptoms, based on
their personal risk profile
• Vaccinate adults at high risk for vaccine-preventable disease
Controversies in Osteoporosis and Management
Carolyn Crandall, MD, MS
• Understand the guidelines and controversies regarding choice,
benefits, and adverse effects of therapy
• Understand the current controversies regarding duration of therapy
and monitoring during therapy
• Advise women about the relative efficacy, risks, and benefits of
commonly used alternatives to systemic hormone therapy for
treatment of menopausal symptoms, including lifestyle changes;
cognitive behavioral therapy; nonhormonal pharmacotherapies;
newly FDA-approved SERM-based therapies; complementary and
alternative therapies; and topical therapies for atrophic vaginitis
Eating Disorders for the Primary Care Clinician
Sindhu Idicula, MD
• Recognize the prevalence of disordered eating and of eating
disorders in the adolescent population
• List common comorbidities and complications of eating disorders
• Recognize at least three medical and psychiatric findings that
require urgent intervention
• Implement steps for identifying patients with eating disorders and
design a preliminary plan of care
• Define anorexia nervosa, bulimia nervosa, and other specified
feeding or eating disorder using new DSM criteria
18
PRI-MED SOUTHWEST
SESSION INFORMATION
Primary Care Approach to Mood Disorders
Alan Craig Swann, MD
Virtual Clinical Coffee Break – Advances and Options
in Female Contraception
• Understand the relevant differential diagnosis of major mood
disorders encountered in primary care
Pelin Batur, MD, FACP, NCMP, CCD
• Understand how psychiatric and non-psychiatric conditions
can interact
• Understand how a patient’s medical background affects
recommended choice of contraceptive
• Be familiar with current treatment strategies for mood disorders
and their rational use
• Review and Update of Drug Therapy for Major Depressive Disorder
Review and Update of Drug Therapy for Major
Depressive Disorder
• Become familiar with the newest contraceptive options available
Ebola Update
• Identify epidemiological risk factors for Ebola Virus Disease
• Recognize clinical features of Ebola Virus Disease
Sanjay Mathew, MD
• Employ measures for prevention of the spread of
Ebola Virus Disease
• Understand pharmacological treatment strategies for patients
with major depressive disorder who inadequately respond to
antidepressant therapy
Cascade Effects in Primary Care Medicine
• Recognize the importance of treating depressive episodes to full
remission
• Review safety and efficacy data for several recently approved
therapies for major depressive disorder
Saturday, March 14, 2015
HALL B3
• Define and describe a concept borrowed from decision psychology
(called “cascade effects”)
• Describe how cascade effects are applicable in primary care
medicine using clinical case examples
• Discuss three different communication and decision-making
techniques to help “break” cascade momentum
Recommendations for Assessing and Treating Irritable
Bowel Syndrome and Its Complications
Dharma, Happiness and Purpose
• Make a positive diagnosis of irritable bowel syndrome (IBS)
• Learn the most recent theories of IBS pathogenesis and their
relevance to diagnosis and treatment
• Recognize that the key to sustained happiness is living with purpose
• Identify four traits of happy individuals
• Recall the “happiness formula” and be able to list the six “happiness
countries”
• Describe the main and recent medical and psychological treatments
of IBS
Diagnosis and Treatment of Gallstone Diseases
Spotlight on Hepatitis C Infection
• Understand epidemiology and risk factors for chronic hepatitis C
• Review the natural history and clinical impact of chronic hepatitis C
infection
Kalpesh Patel, MD
• Describe the signs and symptoms of gallstone disease and related
complications
• Outline a practical algorithm for the diagnosis of gallstone-related
diseases
• Discuss current treatment options of chronic hepatitis C infection
• Provide guidelines for appropriate therapeutic interventions for
specific gallstone-related diseases
A Tale of Two Brains
• Explore the differences between right- and left-brain modes of
engagement
• Understand why a right-brain mode may actually be beneficial for
the clinician
New Approaches to Treating C. Difficile Infection
• Distinguish risk factors for C. difficile Infection (CDI) in an outpatient
with recent diarrheal symptoms
• Consider the pros and cons of treatment modalities
• Employ prevention measures for clinicians, patients, and households
PRI-MED SOUTHWEST
19
SESSION INFORMATION
Clinical Practice Guidelines for the Management
of Thyroid Disorders
Therapeutic Considerations for the Management
of Childhood Obesity
Gregory Brent, MD
• Utilize clinical practice guidelines to diagnose and manage thyroid
nodules and thyroid cancer
• Identify appropriate laboratory screening of obesity-related medical
conditions among overweight or obese youth
• Utilize clinical practice guidelines to diagnose and manage
hypothyroidism
• List current recommendations for lifestyle behavior change to
prevent or treat childhood obesity
• Understand at least two behavior change strategies appropriate for
families that can be promoted in pediatric clinical settings
Virtual Clinical Coffee Break - Practical Tips
for Management of ADHD
Thomas Cummins, MD
Screening Guidelines for Men’s Health
• Identify the core symptoms of ADHD
Radha Rao, MD
• Consider patient factors and the pros and cons of ADHD drugs when
selecting treatment
• Be aware of the latest updates in screening guidelines in the areas
of colon, prostate, and lung cancer
• Be more confident engaging in discussions with patients about
colon, prostate, and lung cancer screening
Walking the Line: A Primer on Gait Analysis
• Decide who gets screened and how often
• Incorporate gait evaluation in determining fall risk in elderly patients
• Recognize gaits that are associated with common musculoskeletal
conditions
Advances in Managing COPD Patients
• Recognize gaits that are associated with common neurological
conditions
• Discuss the impact of COPD
• Link gait abnormalities to historical figures and celebrities
• Outline nonpharmacologic and pharmacologic management
strategies of COP
20
PRI-MED SOUTHWEST
• Review the pathophysiology of COPD
REGISTER
REGISTER FOR NEX T YEAR’S
ANNUAL CONFERENCE FOR JUST $40.
PRI-MED SOUTHWEST
JUNE 23–25, 2016
HOUSTON, T X
Follow the orange footsteps in the Exhibit Hall to the
Pri-Med Booth #301or visit Registration outside Hall B3.
During registration, you’ll also have the opportunity to
purchase a Fitbit activity tracker at a preferred rate.
FACULTY CREDENTIALS FOR PRIMARY CARE UPDATES
AND PRI-MED SOUTHWEST ANNUAL CONFERENCE
Intekhab Ahmend, MD, FACE, FACP
Professor of Medicine
Thomas Jefferson University
Philadelphia, PA
Bipolar Disorders Research Chair
Professor, Department of Psychiatry
Director, Mood Disorders Program
University Hospitals Case Medical Center
Case Western Reserve University School of
Medicine
Cleveland, OH
Chief, Section of Gastroenterology and
Hepatology
Michael E. DeBakey VA Medical Center
Baylor College of Medicine
Houston, TX
Assistant Professor
Adolescent Medicine
Texas Children’s Hospital
Houston, TX
Education Director
Primary Care Women’s Health
Deputy Editor
Cleveland Clinic Journal of Medicine
Cleveland, OH
Lawrence Blonde MD, FACP, FACE
Culley Carson, MD
Professor and Chief,
School of Medicine, Urology
University of North Carolina at Chapel Hill
Chapel Hill, NC
Brooks D. Cash, MD
University of South Alabama
Mobile, AL
Director, Ochsner Diabetes Clinical Research Unit
Department of Endocrinology, Diabetes and
Metabolic Diseases
Ochsner Medical Center
New Orleans, LA
Jessica Castle, MD
Atlanta Diabetes Associates
Clinical Associate Professor
Emory University
Atlanta, GA
Harvard Medical School
James Tullis Firm Chief, Department of Medicine
Beth Israel Deaconess Medical Center
Boston, MA
Gregory Brent, MD
Professor of Medicine and Physiology
David Geffen School of Medicine
University of California
Los Angeles, CA
Los Angeles, CA
Thomas Cummins, MD
Assistant Professor of Medicine & Medical Ethics
Center for Medical Ethics & Health Policy
Director, Bioethics Program
Houston Methodist (System)
Houston, TX
Medical Director of Inpatient Psychiatry Services
Department of Child and Adolescent Psychiatry
The Ann and Robert H. Lurie Children’s Hospital
of Chicago
Assistant Professor
Department of Psychiatry and Behavioral
Sciences
Northwestern University Feinberg School of
Medicine
Chicago, IL
Adjunct Associate Professor of Geriatrics
Philadelphia College of Osteopathic Medicine
Associate Professor of Medicine
Thomas Jefferson University
Philadelphia, PA
Senior Advisor, Lankenau Medical Associates
Lankenau Medical Center
Wynnewood, PA
22
PRI-MED SOUTHWEST
Assistant Professor
Oregon Health & Science University
Portland, OR
Vice Chief of Gastroenterology
Assistant Professor of Medicine
University of North Carolina
Chapel Hill, NC
The William and Sonja Connor Chair of Preventive
Cardiology
Director of Preventive Cardiology
Knight Cardiovascular Institute
Oregon Health and Science University
Portland, OR
Boston University School of Medicine
Chief, Section of Infectious Diseases
VA Boston Healthcare System
Boston, MA
Director
Asthma and COPD Clinical Research Center
Section of Pulmonary and Critical Care Medicine
Houston, TX
Robert Hopkins, Jr., MD, FACP, FAAP
Professor of Internal Medicine and Pediatrics
University of Arkansas for Medical Sciences
College of Medicine
Little Rock, AR
Sindhu Idicula, MD
Assistant Professor of Psychiatry and Pediatrics
Menninger Department of Psychiatry
Houston, TX
Associate Professor
Department of Medicine
Center for Cardiovascular Disease Prevention
Co-director, Lipid Metabolism and Atherosclerosis
Clinic
Medical Director, Weight Management Center
The Methodist Diabetes and Metabolism Institute
Houston, TX
Ki Park, MD
Associate Professor of Urology
Scott Department of Urology
Houston, TX
Interventional Cardiology
Division of Cardiovascular Medicine
University of Florida
Gainesville, FL
Kalpesh Patel, MD
Cardiovascular Medicine
Brigham and Women’s Hospital
Mallinckrodt Professor of Medicine
Boston, MA
Section of Gastroenterology and Hepatology
Houston, TX
Director, Diabetes Care Center
Professor, Department of Medicine
Division of Metabolism
Endocrinology and Nutrition
Director, Endocrine Fellowship Program
University of Washington
Seattle, WA
Assistant Professor
Staff Physician
Houston, TX
Jefferson Medical College
Philadelphia, PA
Sanjay Matthew, MD
Staff Physician
Marjorie Bintliff Johnson and Raleigh White
Johnson, Jr. Chair for Research in Psychiatry
Associate Professor of Psychiatry
& Behavioral Sciences
Menninger Department of Psychiatry &
Behavioral Sciences
Houston, TX
Professor of Psychiatry and Pharmacology
University of Toronto
Head of Mood Disorders
Psychopharmacology Unit
University Health Network
Toronto, Ontario, Canada
USDA/ARS Children’s Nutrition Research Center
Assistant Professor
Department of Pediatrics
Houston, TX
Radha Rao, MD
Donna H. Ryan, MD
Professor Emerita
Pennington Biomedical Research Center
New Orleans, LA
Professor of Medicine and Surgery
Assistant Professor of Nursing
Los Angeles, CA
Gerald Smetana, MD
Division of General Medicine
Beth Israel Deaconess Medical Center
Boston, MA
Co-Director, Lipid Clinic
Los Angeles, CA
Holly Wyatt, MD
Division of Endocrinology, Metabolism and
Diabetes
Medical Director, The Wellness Clinic
Associate Director
Anschutz Health and Wellness Center
University of Colorado Denver
Anschutz Medical Campus
Aurora, CO
Director of Research, Olmsted Medical Center
Adjunct Professor
Department of Family and Community Health
University of Minnesota
Rochester, MN
Professor
Menninger Department of Psychiatry
and Behavioral Sciences
Houston, TX
Dean Ornish, MD
Founder and President
Preventive Medicine Research Institute
Clinical Professor of Medicine
Cardiff, CA
PRI-MED SOUTHWEST
23
FINANCIAL DISCLOSURES
Primary Care Updates Faculty
No financial relationships to disclose.
Not available at time of print.
M. Susan Burke, FACP, MD
Roger S. McIntyre, MD
Speaking honoraria from Merck and Co, Inc.
Receives grant/research support from Abbott, AstraZeneca, Cephalon,
Inc., Cleveland Foundation, Department of Defense, Eli Lilly and
Company, GlaxoSmithKline, Health Resources Services Administration,
H. Lundbeck A/S, National Alliance for Research on Schizophrenia and
Depression (NARSAD), National Institutes of Mental Health (NIMH) and
Stanley Medical Research Institute. He receives honoraria for his role as
a consultant to Biomedical Development Corp., Convergent Health
Solutions, LLC, Dainippon Sumitomo Pharma Co., Ltd., Élan Corporation
plc, Forest Laboratories, Inc., GlaxoSmithKline, Health & Wellness
Partners of New Jersey, LLC, F. Hoffmann-La Roche Ltd, Eli Lilly and
Company, H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd., Pfizer, Inc.,
Sunovion Pharmaceuticals Inc., Takeda Pharmaceutical Company
Limited, and Web ID. He also receives honoraria for his role as a speaker
from AstraZeneca, Benecke CME, Dainippon Sumitomo Pharma Co.,
Ltd., Élan Corporation plc, Forest Laboratories, Inc., GlaxoSmithKline,
Health & Wellness Partners of New Jersey, LLC, H. Lundbeck A/S,
Medwiz Healthcare Communication Pvt. Ltd., Otsuka Pharmaceutical
Co., Ltd., ProMedica, ScientiaCME, LLC., Spirant Communication Pvt.
Ltd., Sunovion Pharmaceuticals Inc., Takeda Pharmaceutical Company
Limited, and Teva Pharmaceutical Industries, Ltd.
Receives grant/research support from AstraZeneca, Eli Lilly and
Company, Janssen Pharmaceuticals, Inc., H. Lundbeck A/S, National
Alliance for Research on Schizophrenia and Depression (NARSAD),
National Institutes of Mental Health, Pfizer, Inc., Shire Plc, and Stanley
Medical Research Institute. He receives honoraria for his role on advisory
boards from AstraZeneca, Bristol-Myers Squibb and Company, Eli Lilly
and Company, France Foundation, GlaxoSmithKline, Janssen
Pharmaceuticals, Inc., H. Lundbeck A/S, Merck & Co., Organon, Pfizer, Inc.,
and Shire Plc. He also receives honoraria for his role as a speaker from
AstraZeneca, Bristol-Myers Squibb and Company, Eli Lilly and Company,
France Foundation, Janssen Pharmaceuticals, Inc., H. Lundbeck A/S,
Merck & Co., and Pfizer, Inc.
Donna H. Ryan, MD
Is part of a speakers bureau for Eisai Co, Ltd, Janssen Pharmaceuticals,
Inc, Novo Nordisk, Takeda Pharmaceuticals USA, Inc, and Vivus, Inc.
Additionally, she has equity interest in Scientific Intake.
Dance Trence, MD, FACE
Is a stock owner of Medtronic and Sanofi.
Holly Wyatt, MD
Receives Consulting fees from Zx Pharma; Medical Advisory Board fees
from Forest, Ironwood, Paion, Salix, and Takeda; Speakers Bureau
honorarium from Forest, Ironwood, Salix, and Takeda.
Dr Lacy receives Medical Advisory Board fees from Forest, Furiex,
Ironwood, and Salix.
Is part of a medical advisory board for Atkins Nutritionals, Inc; Eisai Co,
Ltd; Retrofit, Inc; and Vivus, Inc. She also serves as a research consultant
for Takeda Pharmaceuticals USA, Inc, and Wellspring; receives research
support from the American Beverage Association, GI Dynamics, and
Novo Nordisk Inc; and is a stockholder in Active Planet. Additionally,
she receives royalties from UptoDate, Inc, and owns a patent in
Energy Gap.
Jessica Castle, MD
Brooks D. Cash, MD
Served on the Speaker’s Bureau for Bristol-Meyers Squibb and as a
consultant for Biodel.
Is an ad hoc consultant to investors and marketers.
Is a consultant for Atherotech, a member of the Speakers Bureau for
Merck, and a member of the Medical Advisory Board for Merck,
Amgen, Sanofi/Regeneron.
24
PRI-MED SOUTHWEST
Receives research funding from Boehringer Ingelheim.
Primary Care Updates Planning
and Review Disclosures
Nonfaculty contributors to planning, content development, and
editing and review of content for Primary Care Updates, representing
pmiCME (including staff, advisory boards, consultants, and
contractors); the American College of Physicians; Horizon CME;
Institute for Medical and Nursing Education; Integritas
Communications Group; Medtelligence, LLC; Miller Medical
Communications, LLC; and Tufts Healthcare Institute have nothing
to disclose.
FINANCIAL DISCLOSURES
Annual Conference Faculty
Sindhu Idicula, MD
Consultant to AMS, Auxilium, and Coloplast.
Gregory Brent, MD
Is a consultant for AstraZeneca, Bristol-Myers Squibb, Eisai Inc,
GlaxoSmithKline, Janssen Pharmaceuticals, Inc., Merck & Co., Inc, Novo
Nordisk, Quest Diagnostics, and sanofi-aventis. His institution, Ochsner
Clinic Foundation, received grant/research support from Eli Lilly and
Company, Novo Nordisk, and Sanofi. He is a member of the speakers’
bureaus for Amylin Pharmaceuticals, Inc., AstraZeneca, Bristol-Myers
Squibb, Eisai Inc, GlaxoSmithKline, Janssen Pharmaceuticals Inc,
Merck & Co., Inc., Novo Nordisk, Quest Diagnostics, and Sanofi.
Serves as an unpaid consultant to Amgen; AstraZeneca; Boehringer
Ingelheim; Bristol Myers Squibb; Esperion Therapeutics; Genzyme;
GlaxoSmithKline; Merck & Co., Inc.; Novartis Pharmaceuticals
Corporation; Pfizer, Inc.; and Sanofi-Regeneron. He also serves on the
Scientific Advisory Board for Athera Biotechnologies and Interleukin
Genetics. Dr Libby’s laboratory receives research funding from General
Electric, GlaxoSmithKline and Novartis Pharmaceuticals Corporation.
Sanjay Matthew, MD
Serves on advisory board and receives consulting fees from Genentech.
Serves as a consultant and receives consulting fees from Naurex and
Cerecor. Does contracted research and receives grants from Janssen.
Serves on the Speakers’ Bureau for Lilly, Novo Nordisk, Sanofi,
Medtronic, Merck, Janssen, and AstraZeneca. He is on the Medical
Advisory Boards for Novo Nordisk, Sanofi, Medtronic, and Janssen. He
receives contracted research fees from Novo Nordisk, Sanofi, Medtronic,
Mannkind, and NIH.
Culley Carson, MD
Ki Park, MD
Dean Ornish, MD
Receives consultant honorarium from AbbVie and is a Speaker and
Consultant for Auxilim and AMS.
Janet Pregler, MD, FACP
Radha Rao, MD
Thomas Cummins, MD
Advisory Committee, stock ownership, and speaker for Gilead, BMS,
AbbVie, and Merck.
Kalpesh Patel, MD
Consulting fees from Boehringer Ingelheim GmbH and Melinta
Therapeutics. She and her spouse hold an ownership interest in Sarepta
Therapeutics, Inc.; Seattle Genetics; Antares Pharma, Inc.; and Novartis.
Spouse is employed by Novartis Corporation.
Receives speaking and content development honorarium from Otsuka,
Bristol Myers Squibb. Receives research report as a co-investigator in a
grant for Janssen.
Nicola Hanania, MD
Merck clinical trials adjudicator.
Serves as a contractor and receives grants from GSK, Mylan, BI,
Sunovion, Pearl, Novartis, and Pfizer. Receives speaking and teaching
honorarium for Genentech. Receives honorarium as a consultant for
Genentech, Novartis, Pfizer, BI, GSK, and Sunovion.
Annual Meeting Planning
and Review Disclosures
Robert H. Hopkins, Jr., MD, FACP, FAAP
Nonfaculty contributors to planning, content development, and editing
and review of content for the annual meeting representing pmiCME
(including staff, advisory boards, consultants, and contractors),
American College of Physicians, Baylor College of Medicine and Tufts
Healthcare Institute have nothing to disclose.
PRI-MED SOUTHWEST
25
EXHIBITORS BY ALPHABETICAL LISTING
Kareo. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 223
www.kareo.com
Laclede Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 503
AbbVie. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 417
Akrimax Pharmaceuticals LLC . . . . . . . . . . . . . . . . . . . . . 519
www.laclede.com
Amarin Pharma, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 123
Amazing Charts. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 203
Lippincott Williams & Wilkins. . . . . . . . . . . . . . . . . . . . . . 108
Maico Diagnostics. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 217
Merck. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 403
Micro Direct, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 416
www.akrimax.com
www.amazingcharts.com
American College of Physicians. . . . . . . . . . . . . . . . . . . . 601
American Express Open. . . . . . . . . . . . . . . . . . . . . . . . . . . 100
Life Extension. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 612
www.lef.org
www.micro-direct.com
www.open.com
Mission Pharmacal Co. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 112
AMGEN. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 508
Arbor Pharmaceuticals, Inc. . . . . . . . . . . . . . . . . . . . . . . . 424
Auxilium Pharmaceuticals, Inc. . . . . . . . . . . . . . . . . . . . . 331
www.missionpharmacal.com/
Monthly Prescribing Reference. . . . . . . . . . . . . . . . . . . . 610
Neilmed Pharmaceuticals, Inc.. . . . . . . . . . . . . . . . . . . . . 216
Bionix Medical Technologies. . . . . . . . . . . . . . . . . . . . . . 505
Orasure Technologies, Inc. . . . . . . . . . . . . . . . . . . . . . . . . 427
www.BionixMED.com
www.orasure.com
Bluejay Pharmacy, LLC. . . . . . . . . . . . . . . . . . . . . . . . . . . . 521
Calmoseptine, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 110
www.irestmassager.com
www.Auxilium.com
www.calmoseptine.com
Cell Science Systems/ALCAT. . . . . . . . . . . . . . . . . . . . . . . 218
www.alcat.com
Christus Health. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 538
CryoProbe . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117
www.cryoprobe-na.com
Daiichi Sankyo, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 137
www.daiichisankyo.com
Eisai, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 109
www.neilmed.com
Otto Trading, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 623
P&G Healthcare . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 319
www.pg.com
Pfizer Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 408
www.pfizer.com
Pri-Med. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 301
Pri-Med InLight EHR. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 302
www.inlightehr.com
Qiagen, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 317
www.qiagen.com
Elsevier Medical Books. . . . . . . . . . . . . . . . . . . . . . . . . . . . 104
Quest Diagnostics Incorporated. . . . . . . . . . . . . . . . . . . 219
Salix Pharmaceuticals, Inc. . . . . . . . . . . . . . . . . . . . . . . . . 500
www.eisai.com
www.elsevier.com
www.salix.com
Enovative Technologies. . . . . . . . . . . . . . . . . . . . . . . . . . . 643
Sanofi Pasteur Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 422
www.enovativetech.com
www.aventis.com
Galderma Laboratories LP. . . . . . . . . . . . . . . . . . . . . . . . . 323
GenoVive Weight Management . . . . . . . . . . . . . . . . . . . 418
Shader Productions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 627
www.rockmecz.com
www.genovive.com
Gensco Laboratories. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 504
www.genscolabs.com
Gilead Sciences. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 101
www.gilead.com
Gilead Sciences. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 102
www.gilead.com
GlaxoSmithKline. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 119
www.gsk.com
Grifols USA, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 517
www.grifolsusa.com
Hemosure. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 525
Shire U.S. Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 227
www.shire.com
Summit Doppler Systems. . . . . . . . . . . . . . . . . . . . . . . . . 608
www.summitdoppler.com
Surgeons Practice Solution. . . . . . . . . . . . . . . . . . . . . . . . 438
http://carpaltunnelpros.com/
The Gideons International. . . . . . . . . . . . . . . . . . . . . . . . . 625
www.gideons.org
Ultimate Creations. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 617
www.infinitealoe.com
US Army Medicine Civilian Corp. . . . . . . . . . . . . . . . . . . 401
www.civilianmedicaljobs.com/
I.C.E., Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 637
VIVUS, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 430
Whitaker Medical . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 523
Janssen Pharmaceuticals, Inc. . . . . . . . . . . . . . . . . . . . . . 209
Xenna Corp.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 220
www.hemosure.com
http://infinitetherapeutics.com/
26
PRI-MED SOUTHWEST
http://whitakermedical.com
www.xenna.com
Clinicians Love
Amazing Charts
Integrated Practice
Management
Now Available!
“ Unlike other EHRs, Amazing Charts actually lets me have more
face-to-face time with patients.”
– Dr. James Legan
“I felt comfortable switching from our former EHR to Amazing Charts.
They were very responsive to any issues we had during our transition.”
– Dr. Vishal Datta
“ Amazing Charts is so easy to use we actually get home in time for dinner.
Our kids can’t believe it!”
– Drs. Jennifer and David Benson
Start your FREE trial at booth #203
866-382-5932
[email protected]
www.amazingcharts.com
EXHIBITORS BY PRODUCT CATEGORY
Nutrition & Wellness
GenoVive Weight Management . . . . . . . . . . . .418
Life Extension . . . . . . . . . . . . . . . . . . . . . . .612
Academia, Associations or
Non-profit Organizations
American College of Physicians . . . . . . . . . . . 601
Career, Recruitment & Clinician Network
Whitaker Medical . . . . . . . . . . . . . . . . . . . 523
Consumer Products & Services
Enovative Technologies . . . . . . . . . . . . . . . . 643
I.C.E., Inc. . . . . . . . . . . . . . . . . . . . . . . . . . 637
Otto Trading, Inc. . . . . . . . . . . . . . . . . . . . . 623
P&G Healthcare . . . . . . . . . . . . . . . . . . . . . .319
Shader Productions . . . . . . . . . . . . . . . . . . 627
The Gideons International . . . . . . . . . . . . . . 625
Ultimate Creations . . . . . . . . . . . . . . . . . . . .617
Diagnostics, Laboratories & Testing
Cell Science Systems/ALCAT . . . . . . . . . . . . . .218
Grifols USA, Inc. . . . . . . . . . . . . . . . . . . . . . 517
Hemosure . . . . . . . . . . . . . . . . . . . . . . . . 525
Orasure Technologies, Inc. . . . . . . . . . . . . . . 427
Qiagen, Inc. . . . . . . . . . . . . . . . . . . . . . . . .317
Quest Diagnostics Incorporated . . . . . . . . . . . 219
Financial Services
American Express Open . . . . . . . . . . . . . . . . 100
Government
U.S. Army Medicine Civilian Corp . . . . . . . . . . 401
Healthcare Network or Provider
Christus Health . . . . . . . . . . . . . . . . . . . . . 538
Surgeons Practice Solution . . . . . . . . . . . . . . 438
Medical Device
Bionix Medical Technologies . . . . . . . . . . . . . 505
CryoProbe . . . . . . . . . . . . . . . . . . . . . . . . . 117
Maico Diagnostics . . . . . . . . . . . . . . . . . . . .217
Micro Direct, Inc. . . . . . . . . . . . . . . . . . . . . .416
Summit Doppler Systems . . . . . . . . . . . . . . . 608
Medical Supplies & Equipment
Laclede Inc . . . . . . . . . . . . . . . . . . . . . . . . 503
Miscellaneous
Pri-Med . . . . . . . . . . . . . . . . . . . . . . . . . . 301
28
PRI-MED SOUTHWEST
OTC Medicine and Treatment
Neilmed Pharmaceuticals, Inc. . . . . . . . . . . . . 216
Xenna Corp. . . . . . . . . . . . . . . . . . . . . . . . 220
Pharmaceutical
AbbVie . . . . . . . . . . . . . . . . . . . . . . . . . . .417
Akrimax Pharmaceuticals LLC . . . . . . . . . . . . .519
Amarin Pharma, Inc. . . . . . . . . . . . . . . . . . . .123
AMGEN . . . . . . . . . . . . . . . . . . . . . . . . . . 508
Arbor Pharmaceuticals, Inc. . . . . . . . . . . . . . 424
Auxilium Pharmaceuticals, Inc. . . . . . . . . . . . .331
Calmoseptine, Inc. . . . . . . . . . . . . . . . . . . . .110
Daiichi Sankyo, Inc. . . . . . . . . . . . . . . . . . . .137
Eisai, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . 109
Galderma Laboratories LP . . . . . . . . . . . . . . 323
Gensco Laboratories . . . . . . . . . . . . . . . . . . 504
Gilead Sciences . . . . . . . . . . . . . . . . . . . . . .101
Gilead Sciences . . . . . . . . . . . . . . . . . . . . . 102
GlaxoSmithKline . . . . . . . . . . . . . . . . . . . . .119
Pfizer Inc. . . . . . . . . . . . . . . . . . . . . . . . . 408
Salix Pharmaceuticals, Inc. . . . . . . . . . . . . . . 500
Janssen Pharmaceuticals, Inc. . . . . . . . . . . . . 209
Merck . . . . . . . . . . . . . . . . . . . . . . . . . . . 403
Pharmaceutical
Mission Pharmacal Co. . . . . . . . . . . . . . . . . .
Sanofi Pasteur Inc. . . . . . . . . . . . . . . . . . . . Shire U.S. Inc. . . . . . . . . . . . . . . . . . . . . . . VIVUS, Inc. . . . . . . . . . . . . . . . . . . . . . . . . 112
422
227
430
Pharmacy
Bluejay Pharmacy, LLC . . . . . . . . . . . . . . . . . 521
Practice Management
Amazing Charts . . . . . . . . . . . . . . . . . . . . . 203
Kareo . . . . . . . . . . . . . . . . . . . . . . . . . . . 223
Pri-Med InLight EHR . . . . . . . . . . . . . . . . . . 302
Publishing
Elsevier Medical Books . . . . . . . . . . . . . . . . 104
Lippincott Williams & Wilkins . . . . . . . . . . . . 108
Monthly Prescribing Reference . . . . . . . . . . . .610
CONVENTION CENTER MAPS
Level 3 – Exhibit Halls A3-B3
THEATER #1
THEATER #2
750
351
GEORGE R. BROWN
CONVENTION CENTER
Pri-Med Marketplace
I.C.E., Inc.
Enovative
Technologies
643
627
The
Gideons
International
625
Otto
Trading,
Inc.
623
Pri-Med Marketplace
Pri-Med Marketplace
Shader
Productions
637
Christus
Health
Orasure
Technologies,
Inc.
538
427
Surgeons
Practice
Solution
438
VIVUS,
Inc
430
Auxilium
Pharmaceuticals,
Inc.
331
Daiichi
Sankyo, Inc.
137
130
Reserved
Hemosure
630
525
626
523
Bluejay
Pharmacy,
LLC
622
521
621
520
619
617
615
424
Galderma
Laboratories
LP
422
P&G
Healthcare
418
319
Micro
Direct,
Inc.
126
123
Kareo
222
Quest
Diagnostics
Incorporated
219
Qiagen,
Inc.
416
Amarin
Pharma,
Inc.
223
323
GenoVive
Weight
Management
417
517
325
Sanofi
Pasteur
Inc.
AbbVie
519
Grifols
USA,
Inc.
227
Arbor
Pharmaceuticals,
Inc.
423
Akrimax
Pharmaceuticals
LLC
Ultimate
Creations
326
Recharge
Lounge
Whitaker
Medical
Shire
U.S.
Inc.
Maico
Diagnostics
217
317
Xenna
Corp.
220
GlaxoSmithKline
Cell Science
Systems/
ALCAT
218
119
Neilmed
Pharmaceuticals,
Inc.
216
CryoProbe
117
Pri-Med Marketplace
Mission
Pharmacal
Co
Life
Extension
612
CAFE AREA
Monthly
Prescribing
Reference
610
AMGEN
Summit
Doppler
Systems
508
608
Bionix
Medical
Technologies
605
Pfizer Inc.
604
505
601
Reserved
600
503
501
209
408
Gensco
Laboratories
504
Laclede
Inc
American
College of
Physicians
Janssen
Pharmaceuticals,
Inc.
Salix
Pharmaceuticals,
Inc.
500
Merck
403
Pri-Med
US Army
Medicine
Civilian
Corps
401
301
PriMed Amazing
InLight Charts
EHR
302
203
112
Eisai, Inc.
Calmoseptine,
Inc.
110
Lippincott
Williams &
Wilkins
109
108
Entrance -->
Gilead
Sciences
101
Elsevier
Medical
Books
104
Gilead
Sciences
102
American
Express
Open
100
Lastest Revision: 01292015
PRI-MED SOUTHWEST
29
CONVENTION CENTER MAPS
Level 3
CME
SESSION ROOM #2
CME
SESSION
ROOM #1
GEORGE BUSH
BALLROOM AB
EXHIBIT HALL B3
PRESENTATION
THEATER #3
310 ABC
FACILITY
CONCESSION
REGISTRATION
ENTRANCE
TO EXHIBITS
30
PRI-MED SOUTHWEST
PRI-MED SOUTHWEST - M
GEORGE R. BROWN CONVENTION CENTER
AMAZING CHARTS/
INLIGHT
TRAINING ROOM
332BE
AMAZING CHARTS
INLIGHT
+DPC PANEL
332AD
SYMPOSIA
GEORGE BUSH
BALLROOM C
PRESENTATION
THEATER #4
ROOM 320 AB
SALES OFFICE
ROOM 320 A
WWW.PRI-MED.COM/SOUTHWEST/SYLLABUS
EST - SYLLABUS:
MARCH
13-14, 2015
NEW
MOTHER'S
ROOM
350B
PRI-MED
SHOW
MANAGEMENT
OFFICE
340A
PRI-MED SOUTHWEST
31
THE EHR THAT’S
PROBLEM-ORIENTED
SO YOU CAN BE
PEOPLE-ORIENTED
Visit booth #302 for a demo of the newest
concept in EHRs from the team at
Amazing Charts and Pri-Med.
FREE 60-day trials
now available.
1-844-899-4448 | [email protected]
www.inlightehr.com

Onsite Guide - Pri-Med

Transcription

Similar documents

Welcome to career ServiceS! - Southwest Tennessee Community

These Last Frontier lots have an organ

MTV Latinos - Southwest Solutions

SWEC`s 2008-09 Brochure - Southwest Early College

Wednesday, March 20 6 to 8 p.m. Centerra Mirage Elementary

921 W Mayfield.pub - Arlington

June 2016 - Sri Atmananda Memorial School

Darul Arqam Southwest School

Predicting the Performance of Sort Tooling to 40 Gb/s